Axsome Therapeutics, Inc. (AXSM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Core Insights - The session features Axsome's COO Mark Jacobson and CFO Nick Pizzie, indicating a focus on the company's strategic direction and financial performance [2] Group 1 - The event is part of the Morgan Stanley Global Healthcare Conference, highlighting the importance of healthcare sector discussions [1] - Sean Laaman, Head of U.S. SMID Cap Biotech Equity Research, is leading the session, suggesting a focus on small to mid-cap biotech companies [1]